Novartis’s move to take over UK biotech NeuTec Pharma at a large premium highlights how the so-called “superbugs” have reinvigorated pharma’s interest in antibiotics.

It may not be possible to write a rulebook on how to innovate, but there is no harm in reading attempts to do so.

The University of Manchester is launching a £10 million research centre for developing sustainable energy technologies.

Wine and biotechnology come together in yet another genome project.

European Union has voted to continue funding embryonic stem cell research after a heated debate at the European Parliament on Tuesday.

IBM offers a few details of its new consultancy service for R&D management. Pity about the jargon.

A spin off from ETH-Zürich has devised a new generation of detection equipment that could help in the fight against terrorism. The company is now seeking investment and possible partnerships to take the technology to a commercial level.

The international treaty on plant genetic resources needs a gesture of trust to repair the atmosphere of suspicion that has developed, argues Emile Frison from the International Plant Genetic Resources Institute.

A team of researchers from ETH-Zürich is looking for investment for their spin-off company, XpresSys, to commercialise novel protein expression technology. The technology has the potential to revolutionise screening process for new drugs.

Cuts in federal funding have forced UC Berkeley's RAD Lab to seek industry funding. But the money may not be enough to plug the gap.